http://arrow.latrobe.edu.au:8080/vital/access/manager/Index ${session.getAttribute("locale")} 5 Investigation of TRAIL's capacity to cause mutations in surviving cells. http://arrow.latrobe.edu.au:8080/vital/access/manager/Repository/latrobe:34018 Thu 10 Dec 2015 09:16:36 EST ]]> IAP antagonists synergise with IFNy to activate novel RIPK1 and caspase mediated death pathways in cancer cell lines. http://arrow.latrobe.edu.au:8080/vital/access/manager/Repository/latrobe:34029 Thu 10 Dec 2015 09:11:00 EST ]]>